Summary
The National Institutes of Health (NIH) is issuing a single-source funding opportunity (RFA-DK-26-314) to establish a Pilot/Opportunity program leveraging artificial intelligence (AI) models to accelerate diabetes research. The mechanism is a U24 cooperative agreement, and clinical trials are explicitly excluded. This is a forecasted opportunity, meaning it has not yet been formally opened for applications.